JPS63253070A - イミダゾール誘導体 - Google Patents

イミダゾール誘導体

Info

Publication number
JPS63253070A
JPS63253070A JP63063734A JP6373488A JPS63253070A JP S63253070 A JPS63253070 A JP S63253070A JP 63063734 A JP63063734 A JP 63063734A JP 6373488 A JP6373488 A JP 6373488A JP S63253070 A JPS63253070 A JP S63253070A
Authority
JP
Japan
Prior art keywords
hydroxy
formula
tert
compound according
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63063734A
Other languages
English (en)
Japanese (ja)
Inventor
ウイルヘフム・クレツツアー
マルク・モンタボン
レナーテ・ミユスナー
ニコラス・ジンゲバルト
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JPS63253070A publication Critical patent/JPS63253070A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP63063734A 1987-03-20 1988-03-18 イミダゾール誘導体 Pending JPS63253070A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH107387 1987-03-20
CH01073/87-9 1987-03-20

Publications (1)

Publication Number Publication Date
JPS63253070A true JPS63253070A (ja) 1988-10-20

Family

ID=4201822

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63063734A Pending JPS63253070A (ja) 1987-03-20 1988-03-18 イミダゾール誘導体

Country Status (23)

Country Link
US (1) US4908363A (OSRAM)
EP (1) EP0283857B1 (OSRAM)
JP (1) JPS63253070A (OSRAM)
KR (1) KR880011117A (OSRAM)
CN (1) CN1016169B (OSRAM)
AT (1) ATE73777T1 (OSRAM)
AU (1) AU613349B2 (OSRAM)
CS (1) CS276093B6 (OSRAM)
DE (1) DE3869163D1 (OSRAM)
DK (1) DK59888A (OSRAM)
ES (1) ES2032482T3 (OSRAM)
FI (1) FI880813A7 (OSRAM)
GR (1) GR3004729T3 (OSRAM)
HU (1) HU201312B (OSRAM)
IL (1) IL85725A (OSRAM)
MC (1) MC1919A1 (OSRAM)
MX (1) MX10721A (OSRAM)
NO (1) NO170215C (OSRAM)
NZ (1) NZ223862A (OSRAM)
PT (1) PT87025B (OSRAM)
SU (1) SU1657057A3 (OSRAM)
YU (1) YU46444B (OSRAM)
ZA (1) ZA881810B (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073566A (en) * 1989-11-30 1991-12-17 Eli Lilly And Company Angiotensin ii antagonist 1,3-imidazoles and use thereas
US5401851A (en) * 1992-06-03 1995-03-28 Eli Lilly And Company Angiotensin II antagonists
US5612360A (en) * 1992-06-03 1997-03-18 Eli Lilly And Company Angiotensin II antagonists
US5574057A (en) * 1993-02-03 1996-11-12 University Of Utah Research Foundation Naamidine A extracted from sea sponges and methods for its use as an anti-tumor agent
US5523310A (en) * 1994-12-05 1996-06-04 Hoffmann-La Roche Inc. 1,2,3-triazole derivatives
WO2000031052A1 (en) 1998-11-23 2000-06-02 F. Hoffmann-La Roche Ag Synthesis of anti-inflammatory [1,2,3]triazoles
DE10132896A1 (de) * 2001-07-06 2003-01-16 Bayer Cropscience Ag Heterocyclische Amidderivate
WO2003010143A1 (en) * 2001-07-26 2003-02-06 Samsung Electronics Co., Ltd. Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
US6737433B1 (en) * 2002-12-16 2004-05-18 Laboratoire Theramex 1-N-phenylamino-1H-imidazole derivatives as aromatase inhibitors and pharmaceutical compositions containing them
JP2004196795A (ja) * 2002-12-16 2004-07-15 Wyeth 外部寄生虫駆除剤としてのｎ−フェニル−３−シクロプロピルピラゾール−４−カルボニトリル

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4457859A (en) * 1980-07-31 1984-07-03 Ivaschenko Alexandr V Mesomorphic material containing 2,2'-azoimidazole compounds containing 1,1'-benzylideneamino substituents
DE3674054D1 (de) * 1985-04-26 1990-10-18 Hoffmann La Roche 1,3-disubstituierte imidazoliumsalze.
ZW6687A1 (en) * 1986-05-13 1987-12-02 Hoffmann La Roche 1,3-disubstituted imidazolium salts
MW7087A1 (en) * 1986-10-03 1988-05-11 Hoffmann La Roche 1,3-disubstituted imidazolium salts
KR890700582A (ko) * 1987-03-20 1989-04-25 사무엘 에스. 블라이트 살진균성 아미노트리아졸 및 아미노이미다졸

Also Published As

Publication number Publication date
PT87025B (pt) 1992-06-30
HUT49581A (en) 1989-10-30
CN88101452A (zh) 1988-10-05
MX10721A (es) 1993-09-01
DK59888D0 (da) 1988-02-05
MC1919A1 (fr) 1989-04-06
ATE73777T1 (de) 1992-04-15
FI880813A0 (fi) 1988-02-22
FI880813A7 (fi) 1988-09-21
ES2032482T3 (es) 1993-02-16
CN1016169B (zh) 1992-04-08
CS8800891A2 (en) 1990-09-12
NO881199D0 (no) 1988-03-18
ZA881810B (en) 1988-09-20
IL85725A (en) 1991-12-12
NZ223862A (en) 1990-08-28
NO170215B (no) 1992-06-15
YU46444B (sh) 1993-10-20
NO170215C (no) 1992-09-23
IL85725A0 (en) 1988-08-31
GR3004729T3 (OSRAM) 1993-04-28
CS276093B6 (en) 1992-04-15
HU201312B (en) 1990-10-28
NO881199L (no) 1988-09-21
YU40388A (en) 1990-02-28
PT87025A (pt) 1988-04-01
EP0283857A1 (de) 1988-09-28
DE3869163D1 (de) 1992-04-23
AU1353288A (en) 1988-09-22
AU613349B2 (en) 1991-08-01
KR880011117A (ko) 1988-10-26
DK59888A (da) 1988-09-21
EP0283857B1 (de) 1992-03-18
US4908363A (en) 1990-03-13
SU1657057A3 (ru) 1991-06-15

Similar Documents

Publication Publication Date Title
EP0081324B1 (en) Substituted pharmacologically acitve imidazole derivatives and their preparation and use
US4348404A (en) Antiinflammatory 4,5-diaryl-α-polyfluoroalkyl-1H-imidazole-2-methanamines
JPS63253070A (ja) イミダゾール誘導体
US3868457A (en) Method of inhibiting histamine activity with guanidine compounds
EP0144853B1 (en) Semicarbazide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
GB1569251A (en) Pyridobenzodiazepines
EP0165782B1 (en) Pyrazole compounds
US5124334A (en) Benzylalcohol phospholipase A2 inhibitors
US5281711A (en) (S)-1-[10-chloro-6,7-dihydro-4-oxo-3-phenyl-4H-benzo[a]quino-lizin-1-yl)carbonyl]-3-ethoxypyrrolidine
HK1005179A1 (en) Substituted 3,4-dihydronaphthalenes, medicament containing them and process for their preparation
US3092660A (en) 1-acyl-2-alkyl-hydrazine derivatives
EP0002672A2 (de) Substituierte Pyrrolidine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
HK1005179B (en) Substituted 3,4-dihydronaphthalenes, medicament containing them and process for their preparation
US4115641A (en) Ribofuranosyl-imidazole derivatives
US4788209A (en) Antifungal 2-anilinothiazolines
US3801581A (en) Alpha-phenyl-fatty acids substituted by azacycloalkyl residues and their derivatives
US4138482A (en) 3-Cyano-N-(N,N-dimethylaminopropyl)-iminodibenzyl and salts thereof
US3676439A (en) 5,6-dihydro-8,8-dimethyl-3-nitro-8h imidazo(2-1-c) (1,4)oxazine
US4600721A (en) Pharmaceutical preparation
EP0032113A2 (en) Antiinflammatory 4,5-diaryl-alpha-(polyhaloalkyl)-1H-imidazole-2-methanols
US4370339A (en) Method for treating inflammatory conditions
US3864359A (en) 5-amino-3-ethyl-1-phenyl-4-pyrazolecarboxamides and method of preparation thereof
HU195655B (en) Process for producing 8-beta-ergolinyl-methyl derivatives and pharmaceutical compositions containing them
PL72585B1 (en) 6-methyl-8-piperazinyl-methylergalene (ergoline) derivatives[us3583991a]
US3557100A (en) Certain decahydro and dodecahydro-5h-pyrido(1,2-a) - 1,6 - naphthyridine - 5 - ones,the corresponding - 5 - ols and derivatives thereof